rs144055758
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (A;A) | 0 | common in clinvar |
| (A;G) | 3 | cystic fibrosis carrier (most likely) |
| Make rs144055758(G;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 7 |
| Position | 117610625 |
| Gene | CFTR |
| is a | snp |
| is | mentioned by |
| dbSNP | rs144055758 |
| dbSNP (classic) | rs144055758 |
| ClinGen | rs144055758 |
| ebi | rs144055758 |
| HLI | rs144055758 |
| Exac | rs144055758 |
| Gnomad | rs144055758 |
| Varsome | rs144055758 |
| LitVar | rs144055758 |
| Map | rs144055758 |
| PheGenI | rs144055758 |
| Biobank | rs144055758 |
| 1000 genomes | rs144055758 |
| hgdp | rs144055758 |
| ensembl | rs144055758 |
| geneview | rs144055758 |
| scholar | rs144055758 |
| rs144055758 | |
| pharmgkb | rs144055758 |
| gwascentral | rs144055758 |
| openSNP | rs144055758 |
| 23andMe | rs144055758 |
| SNPshot | rs144055758 |
| SNPdbe | rs144055758 |
| MSV3d | rs144055758 |
| GWAS Ctlg | rs144055758 |
| Max Magnitude | 3 |
aka c.3095A>G, p.Tyr1032Cys or Y1032C
In the CFTR2 database, the minor allele is considered to be of varying clinical consequence. In a functional study, it shows 20.6% of wild-type CFTR activity.[PMID 29805046
]
| ClinVar | |
|---|---|
| Risk | rs144055758(G;G) |
| Alt | rs144055758(G;G) |
| Reference | Rs144055758(A;A) |
| Significance | Pathogenic |
| Disease | Cystic fibrosis |
| Variation | info |
| Gene | CFTR |
| CLNDBN | Cystic fibrosis |
| Reversed | 0 |
| HGVS | NC_000007.13:g.117250679A>G |
| CLNSRC | ClinVar LabCorp |
| CLNACC | RCV000029516.2, |
[PMID 9272157] Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens.
[PMID 12133923] Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
[PMID 16801189] Identification of the 5T-12TG allele of the cystic fibrosis transmembrane conductance regulator gene in hypertrypsinaemic newborns.
[PMID 20059485] Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?
